Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Original Research
Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,921 | Dovepress* | 2,540+ | 89 | 2,629 | |
| PubMed Central* | 381 | 94 | 475 | ||
| Totals | 2,921 | 183 | 3,104 | ||
| *Since 28 December 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar